Concepts (182)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Enhancer Elements, Genetic | 18 | 2013 | 63 | 2.350 |
Why?
|
| Immunoglobulin Heavy Chains | 24 | 2013 | 57 | 2.330 |
Why?
|
| B-Lymphocytes | 19 | 2013 | 183 | 1.650 |
Why?
|
| Genes, Immunoglobulin Heavy Chain | 3 | 2013 | 6 | 1.060 |
Why?
|
| Genes, Immunoglobulin | 12 | 2001 | 37 | 1.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 5 | 2013 | 50 | 0.800 |
Why?
|
| DNA-Binding Proteins | 8 | 2005 | 557 | 0.660 |
Why?
|
| Transcription Factors | 8 | 2003 | 722 | 0.640 |
Why?
|
| Receptors, Antigen, B-Cell | 4 | 2013 | 21 | 0.550 |
Why?
|
| Immunoglobulins | 4 | 2011 | 39 | 0.510 |
Why?
|
| Lymphoma, T-Cell | 7 | 2003 | 29 | 0.500 |
Why?
|
| Mice | 35 | 2013 | 6490 | 0.480 |
Why?
|
| 3' Untranslated Regions | 3 | 2007 | 81 | 0.480 |
Why?
|
| T-Lymphocytes | 10 | 2005 | 378 | 0.470 |
Why?
|
| Transcription, Genetic | 11 | 2010 | 599 | 0.450 |
Why?
|
| Immunoglobulin mu-Chains | 3 | 2008 | 6 | 0.440 |
Why?
|
| Alleles | 3 | 2011 | 352 | 0.430 |
Why?
|
| Precursor Cells, B-Lymphoid | 1 | 2013 | 4 | 0.420 |
Why?
|
| Plasmacytoma | 8 | 2003 | 11 | 0.410 |
Why?
|
| Hybrid Cells | 9 | 2005 | 20 | 0.390 |
Why?
|
| Gene Expression Regulation | 12 | 2001 | 1066 | 0.380 |
Why?
|
| Recombination, Genetic | 3 | 2011 | 96 | 0.360 |
Why?
|
| Immunoglobulin Class Switching | 2 | 2010 | 20 | 0.350 |
Why?
|
| Gene Rearrangement, B-Lymphocyte, Heavy Chain | 2 | 2008 | 11 | 0.350 |
Why?
|
| Somatic Hypermutation, Immunoglobulin | 1 | 2010 | 8 | 0.340 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2007 | 933 | 0.330 |
Why?
|
| 3' Flanking Region | 2 | 2007 | 3 | 0.330 |
Why?
|
| Animals | 35 | 2013 | 16695 | 0.320 |
Why?
|
| Translocation, Genetic | 3 | 2007 | 40 | 0.300 |
Why?
|
| Sequence Deletion | 3 | 2011 | 92 | 0.290 |
Why?
|
| Immunoglobulin alpha-Chains | 2 | 2007 | 4 | 0.280 |
Why?
|
| Cell Fusion | 6 | 2005 | 19 | 0.280 |
Why?
|
| Immunoglobulin Constant Regions | 2 | 2007 | 3 | 0.270 |
Why?
|
| Burkitt Lymphoma | 1 | 2007 | 25 | 0.270 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2007 | 62 | 0.270 |
Why?
|
| Immunoglobulin A | 1 | 2007 | 63 | 0.260 |
Why?
|
| Multiple Myeloma | 4 | 1995 | 45 | 0.260 |
Why?
|
| Antibody-Producing Cells | 2 | 2001 | 6 | 0.240 |
Why?
|
| Mice, Inbred BALB C | 9 | 2003 | 686 | 0.240 |
Why?
|
| Hybridomas | 5 | 2003 | 24 | 0.230 |
Why?
|
| Trans-Activators | 2 | 2003 | 190 | 0.230 |
Why?
|
| Flow Cytometry | 3 | 2011 | 411 | 0.220 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 649 | 0.210 |
Why?
|
| Base Sequence | 10 | 2011 | 997 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2011 | 658 | 0.200 |
Why?
|
| Immunoglobulin gamma-Chains | 5 | 1994 | 6 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2013 | 1804 | 0.190 |
Why?
|
| Mice, Knockout | 4 | 2013 | 1010 | 0.190 |
Why?
|
| Tumor Cells, Cultured | 7 | 2001 | 506 | 0.180 |
Why?
|
| Blotting, Southern | 3 | 2011 | 68 | 0.180 |
Why?
|
| Cell Line | 12 | 2001 | 1416 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 2011 | 456 | 0.170 |
Why?
|
| Myeloma Proteins | 2 | 1995 | 2 | 0.170 |
Why?
|
| Immunoglobulin G | 4 | 1990 | 253 | 0.170 |
Why?
|
| Transfection | 7 | 2003 | 526 | 0.170 |
Why?
|
| Lymphoma | 3 | 1989 | 38 | 0.160 |
Why?
|
| Cells, Cultured | 3 | 2013 | 1617 | 0.150 |
Why?
|
| Spleen | 3 | 2008 | 199 | 0.150 |
Why?
|
| Cell Differentiation | 3 | 2013 | 633 | 0.150 |
Why?
|
| Octamer Transcription Factor-2 | 4 | 2003 | 7 | 0.150 |
Why?
|
| Bone Marrow Cells | 2 | 2008 | 79 | 0.140 |
Why?
|
| Mice, Inbred AKR | 4 | 2003 | 5 | 0.140 |
Why?
|
| Chromosomes | 1 | 1998 | 44 | 0.140 |
Why?
|
| RNA, Messenger | 5 | 2013 | 1265 | 0.120 |
Why?
|
| Electroporation | 1 | 1995 | 21 | 0.120 |
Why?
|
| DNA, Neoplasm | 3 | 1998 | 92 | 0.110 |
Why?
|
| Molecular Sequence Data | 6 | 1995 | 1559 | 0.110 |
Why?
|
| Immunoglobulin Fragments | 1 | 2013 | 12 | 0.100 |
Why?
|
| Immunoglobulin kappa-Chains | 2 | 2008 | 9 | 0.100 |
Why?
|
| Neoplasm Proteins | 1 | 1995 | 228 | 0.100 |
Why?
|
| Gene Expression | 3 | 2008 | 692 | 0.100 |
Why?
|
| DNA Primers | 2 | 2011 | 295 | 0.100 |
Why?
|
| Antibodies, Monoclonal | 3 | 1995 | 301 | 0.100 |
Why?
|
| Histocompatibility Antigens Class II | 2 | 1989 | 31 | 0.100 |
Why?
|
| Antigen-Presenting Cells | 2 | 1989 | 31 | 0.100 |
Why?
|
| Transgenes | 2 | 2003 | 65 | 0.100 |
Why?
|
| Promoter Regions, Genetic | 4 | 2007 | 534 | 0.090 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2011 | 15 | 0.090 |
Why?
|
| Models, Genetic | 3 | 1997 | 181 | 0.090 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 15 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2013 | 973 | 0.080 |
Why?
|
| Genes, Regulator | 2 | 1992 | 27 | 0.080 |
Why?
|
| Immunoglobulin M | 2 | 2008 | 87 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 94 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2007 | 2598 | 0.080 |
Why?
|
| VDJ Exons | 1 | 2008 | 1 | 0.080 |
Why?
|
| Hinge Exons | 1 | 2008 | 1 | 0.080 |
Why?
|
| Immunoglobulin lambda-Chains | 1 | 2008 | 3 | 0.080 |
Why?
|
| Immunoglobulin D | 1 | 2008 | 6 | 0.080 |
Why?
|
| Cloning, Molecular | 5 | 1993 | 318 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2008 | 16 | 0.080 |
Why?
|
| Lipopolysaccharides | 2 | 2007 | 235 | 0.070 |
Why?
|
| Phenotype | 2 | 2003 | 774 | 0.070 |
Why?
|
| Clone Cells | 2 | 2003 | 50 | 0.070 |
Why?
|
| Homeodomain Proteins | 1 | 2008 | 144 | 0.070 |
Why?
|
| DNA Replication | 2 | 2005 | 153 | 0.070 |
Why?
|
| DNA | 4 | 1996 | 594 | 0.070 |
Why?
|
| Plasma Cells | 2 | 1998 | 11 | 0.060 |
Why?
|
| Introns | 3 | 2000 | 80 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2005 | 47 | 0.060 |
Why?
|
| Genetic Markers | 2 | 2005 | 146 | 0.060 |
Why?
|
| Genes | 3 | 1984 | 56 | 0.060 |
Why?
|
| Chromosome Mapping | 2 | 1998 | 198 | 0.050 |
Why?
|
| Oncogenes | 4 | 1992 | 44 | 0.050 |
Why?
|
| Muromegalovirus | 1 | 2003 | 9 | 0.050 |
Why?
|
| Histones | 1 | 2005 | 194 | 0.050 |
Why?
|
| Cell Nucleus | 1 | 2005 | 383 | 0.050 |
Why?
|
| Chromatin | 1 | 2005 | 179 | 0.050 |
Why?
|
| Rats | 3 | 1998 | 3701 | 0.050 |
Why?
|
| Humans | 8 | 2007 | 42163 | 0.050 |
Why?
|
| Repressor Proteins | 1 | 2005 | 267 | 0.050 |
Why?
|
| Octamer Transcription Factor-1 | 1 | 2001 | 3 | 0.050 |
Why?
|
| Host Cell Factor C1 | 1 | 2001 | 5 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2003 | 255 | 0.050 |
Why?
|
| Mutation | 1 | 1986 | 1169 | 0.050 |
Why?
|
| Gene Dosage | 1 | 2001 | 75 | 0.040 |
Why?
|
| Genes, Reporter | 1 | 2001 | 148 | 0.040 |
Why?
|
| Transcriptional Activation | 2 | 1993 | 173 | 0.040 |
Why?
|
| Gene Silencing | 1 | 2001 | 154 | 0.040 |
Why?
|
| Cell Lineage | 1 | 2001 | 104 | 0.040 |
Why?
|
| Protein Structure, Tertiary | 1 | 2001 | 427 | 0.040 |
Why?
|
| Plasmids | 3 | 1996 | 247 | 0.040 |
Why?
|
| Antigens, Ly | 1 | 1980 | 8 | 0.040 |
Why?
|
| Chromosome Deletion | 2 | 1993 | 53 | 0.040 |
Why?
|
| Deoxyribonuclease I | 2 | 2005 | 28 | 0.040 |
Why?
|
| Antigens, Surface | 1 | 1980 | 50 | 0.040 |
Why?
|
| Peptide Fragments | 1 | 2001 | 301 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 2 | 1998 | 454 | 0.040 |
Why?
|
| Oligonucleotide Probes | 1 | 1998 | 21 | 0.040 |
Why?
|
| DNA Nucleotidylexotransferase | 1 | 1996 | 6 | 0.030 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 1996 | 14 | 0.030 |
Why?
|
| Gene Targeting | 1 | 1995 | 40 | 0.030 |
Why?
|
| CHO Cells | 1 | 1995 | 123 | 0.030 |
Why?
|
| Cricetinae | 1 | 1995 | 241 | 0.030 |
Why?
|
| Genetic Vectors | 1 | 1995 | 165 | 0.030 |
Why?
|
| Immunoglobulin J-Chains | 1 | 1994 | 3 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1993 | 45 | 0.030 |
Why?
|
| Pentosyltransferases | 1 | 1993 | 8 | 0.030 |
Why?
|
| Methylation | 1 | 1993 | 118 | 0.030 |
Why?
|
| Chromosomes, Human | 1 | 1993 | 37 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1994 | 330 | 0.020 |
Why?
|
| Cell Survival | 1 | 1995 | 934 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1993 | 293 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1986 | 13 | 0.020 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1991 | 22 | 0.020 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1991 | 29 | 0.020 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1991 | 90 | 0.020 |
Why?
|
| Escherichia coli | 1 | 1993 | 461 | 0.020 |
Why?
|
| Blotting, Northern | 1 | 1990 | 149 | 0.020 |
Why?
|
| Genes, Dominant | 1 | 1989 | 20 | 0.020 |
Why?
|
| Simian virus 40 | 1 | 1989 | 38 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 2 | 1986 | 71 | 0.020 |
Why?
|
| Interleukin-2 | 1 | 1989 | 90 | 0.020 |
Why?
|
| Epitopes | 1 | 1989 | 155 | 0.020 |
Why?
|
| 3T3 Cells | 2 | 2000 | 61 | 0.020 |
Why?
|
| Chloroquine | 1 | 1988 | 19 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 1988 | 116 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1988 | 522 | 0.020 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2005 | 22 | 0.010 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2005 | 57 | 0.010 |
Why?
|
| Bone Marrow | 1 | 2005 | 35 | 0.010 |
Why?
|
| Locus Control Region | 1 | 2005 | 8 | 0.010 |
Why?
|
| Acetylation | 1 | 2005 | 108 | 0.010 |
Why?
|
| Major Histocompatibility Complex | 1 | 1983 | 27 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1982 | 168 | 0.010 |
Why?
|
| Genetic Variation | 1 | 1983 | 429 | 0.010 |
Why?
|
| Immune Sera | 1 | 2000 | 56 | 0.010 |
Why?
|
| Interleukin-4 | 1 | 2000 | 75 | 0.010 |
Why?
|
| Genes, MHC Class II | 1 | 1980 | 20 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1980 | 76 | 0.010 |
Why?
|
| Drug Synergism | 1 | 2000 | 189 | 0.010 |
Why?
|
| Lymphocyte Activation | 1 | 2000 | 244 | 0.010 |
Why?
|
| TCF Transcription Factors | 1 | 1996 | 17 | 0.010 |
Why?
|
| Fibroblasts | 1 | 1996 | 278 | 0.010 |
Why?
|
| Binding Sites | 1 | 1996 | 670 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1992 | 36 | 0.010 |
Why?
|
| Testis | 1 | 1992 | 203 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 1992 | 1188 | 0.000 |
Why?
|
| Leukemia, Erythroblastic, Acute | 1 | 1984 | 8 | 0.000 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1984 | 9 | 0.000 |
Why?
|
| Endonucleases | 1 | 1984 | 18 | 0.000 |
Why?
|
| Male | 1 | 1992 | 22779 | 0.000 |
Why?
|